Colgate-Palmolive (CL): Chief People Officer sold, ~$752K

~$752K
Approx. value · 8,599 sh @ $87.41: 14K
Holds after · shares reported

Traded: May 7, 2026
Filed: May 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Sep 23, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
Mar 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 12, 2026, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate-Palmolive”) elected Christopher S. Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company (“Bristol Myers Squibb”), to the Colgate-Palmolive Board, effective March 15, 2026.”
Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
Apr 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Jennifer M. Daniels, who has served as Chief Legal Officer and Secretary of Colgate-Palmolive Company (the “Company”) since 2014, has communicated to the Company her intention to retire from the Company in 2026.”
Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
Apr 30, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results“As previously disclosed, on July 31, 2025, the Company’s Board of Directors (“Board”) approved a three-year productivity program to drive future growth and support the Company’s 2030 strategy (the “Strategic Growth and Productivity Program”).”
May 7, 2026 · this disclosureInsiderOfficer sold ~$752K of CL shares in the open market

What came next

May 15, 2026InsiderOfficer sold ~$203K of CL shares in the open market
Jul 31, 2026Company filing · Form 8-K · ResultsReported its results
Aug 4, 2026Insider · Their largest sale since 2009CEO sold ~$14.8M of CL shares in the open market
Aug 5, 2026InsiderCEO sold ~$14.9M of CL shares in the open market
Aug 6, 2026InsiderDirector sold ~$389K of CL shares in the open market
Aug 19, 2026CongressDisclosed sale of CL — reported range $1,001 - $15,000
Aug 24, 2026InsiderOfficer sold ~$920K of CL shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Colgate-Palmolive

For Colgate-Palmolive, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 6 Congress trade reports and 39 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CL page.

Other recent filings by Sally Massey, Chief People Officer

The full history of Sally Massey, Chief People Officer is on the profile page.

Other disclosures at Colgate-Palmolive

Everything OQRO holds on this company is on its CL page.

Colgate-Palmolive (CL)Chief People Officer sold ~$752K